PMC:7755033 / 70019-70753
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
918 | 408-411 | Gene | denotes | PDB | Gene:5131 |
919 | 162-165 | Gene | denotes | PDB | Gene:5131 |
920 | 374-384 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
921 | 511-519 | Species | denotes | SARS-CoV | Tax:694009 |
922 | 524-534 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
926 | 437-444 | Chemical | denotes | 3CL-pro |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T618 | 170-415 | Sentence | denotes | 1P9U; Table 9), whereas anaferine was found to interact with the active site residues Cys145, Glu166, Ser144, Met165, His163, His164, Gln189, Asp187, Arg188, Met49 and His41 present at the active site of SARS-CoV-2 main protease 3CL-pro (PDB ID: |
T619 | 416-432 | Sentence | denotes | 6LU7; Table 10). |
T620 | 433-619 | Sentence | denotes | The 3CL-pro active site has been found to be evolutionarily conserved between SARS-CoV and SARS-CoV-2 (Báez-Santos et al., 2015; Chen et al., 2020; Guy et al., 2005; Zhang et al., 2020). |